Sen. Katie Britt joined Sen. Elissa Slotkin on Sept. 29 to unveil the bipartisan Ovarian Cancer IMPACT Act, legislation aimed at modernizing ovarian cancer prevention and care in the U.S.
The bill, sponsors say, would expand access to genetic and genomic testing and counseling and improve access to risk‑reducing care for people at hereditary risk of ovarian cancer, according to a press release from Britt’s office.
Sen. Elissa Slotkin’s office described the measure as bicameral and bipartisan and said it would require group and individual health plans to cover testing and related counseling, while also strengthening outreach and specialty gynecologic cancer care in underserved areas.
The Hill reported the legislation launches a coordinated push by Democrats and Republicans to improve screening, prevention and specialist access for ovarian and other gynecologic cancers.
Advocacy groups tracking the bill say the Ovarian Cancer IMPACT Act focuses on four areas: awareness and outreach, expanded genetic testing and counseling, risk‑reducing interventions, and improved access to specialized care, OCRA noted in its summary.
How it would work: the sponsors say the measure would direct federal support for provider training and telehealth to connect patients in rural areas with gynecologic oncology specialists, and would expand insurance coverage for genetic services, per Slotkin’s press release.
Congress.gov lists the measure under the current session and records companion actions and text for S.5554, giving readers a way to track amendments and votes as the proposal moves through committees.
Why it matters: ovarian cancer often presents late and hereditary risk factors can be identified earlier through genetic testing, proponents say — expanding coverage and outreach is presented as a way to catch high‑risk cases sooner, according to the sponsors and advocates who commented to news outlets.
Senators Britt and Slotkin framed the bill as a practical, bipartisan response to persistent gaps in prevention and specialty care, and urged colleagues to support committee consideration and floor action this Congress.
For readers tracking related health coverage and personal stories, note recent local reporting on public figures and cancer updates provides additional context about survivorship and treatment narratives.
Sources
- Office of Sen. Katie Britt — press release announcing the bipartisan legislation and outlining expansions to genetic testing, counseling and risk‑reducing care.
- Office of Sen. Elissa Slotkin — press release describing the Ovarian Cancer IMPACT Act and its provisions for insurance coverage, outreach and specialty care.
- The Hill — report on the bipartisan launch and the bill’s goals to improve screening, prevention and specialist access.
- Congress.gov — public bill entry listing text and procedural status (S.5554) for tracking amendments and votes.
- OCRA — advocacy summary describing the bill’s focus areas and its potential impact on prevention and care access.
